BD Diagnostics has launched the BD Max open system for molecular testing, which enables laboratories to run both laboratory and BD-developed assays and to offer enhanced testing services.
Tom Polen, president of BD Diagnostics - Diagnostic Systems, said: 'In a world with ever-evolving pathogens, laboratories need to provide clinicians with fast, accurate and actionable diagnostic information that will save patient lives.
'The new, completely open, state-of-the-art BD Max system empowers laboratories to automate their unique internally developed molecular assays, while accessing a rich and growing menu of world-class assays from BD and our leading assay development partners,' he added.
BD Max is claimed to be the first fully automated, open, bench-top molecular testing workstation able to perform both IVD/CE and laboratory-developed tests.
The system gives clinical laboratory professionals the ability to help their institutions to respond to emerging threats, such as new strains of drug-resistant bacteria or respiratory illnesses.
The BD Max system's content-rich menu, open capability, full automation and standardised workflow will enable laboratories to consolidate and standardise a range of molecular tests to build programs that meet their current and future clinical needs.
The system will give European laboratories the ability to run their current laboratory-developed assays as well as the ability to develop new ones.
